Neurobrave

Software Platform for Analyzing Neural Biomarkers/Insights

Health Tech & Life Sciences
Active
Seed Jerusalem Founded 2020
Total raised
$3.0M
Last: Seed 2022-11
Stage
Seed
Founded
2020
Headcount
23
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

NeuroBrave uses cloud-based infrastructure, advanced signal processing, and DNN proprietary algorithms to create a standardized software solution (NeuroSpeed OS) for analyzing neural biomarkers/insights using any hardware, including smartphones, smartwatches, and many other wearables. NeuroBrave's operating system aims to save money and drastically shorten any neuroscience venture's time to market by automatically extracting and analyzing the desired biomarker.

Funding history · 3 rounds · $3.0M total

2022-11
Seed $1.8M
2021-08
Seed $1.2M
2020-11
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Artificial IntelligenceGenerative AIMachine LearningPlatforms & InterfacesSoftwareSensing
Target customers
Healthcare & Life SciencesHealthcarePatientsConsumersRecreational & LifestyleGamersIndustrial Manufacturing
Business model
B2B

Tags

mental-healthdigital-therapeuticswearablesaasbiomarkerssignal-processinginfrastructureneurologyartificial-intelligencebiosensorswellness